NEPHROS INC (NEPH): Results of Operations and Financial Condition
NEPHROS INC (NEPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202 nephros.com Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026 Record Second-Quarter Net Revenue Growth of 36% to $6 million; Core Program
How this was made
The 30-second read
Why it matters
Traders can update models for NEPH’s recurring programmatic revenue growth (27% YoY in Q2) and assess earnings quality given the explicit one-time tariff refund and the fact that the cash refund has not yet been received (receivable booked).
Market read
A microcap earnings release with record quarterly revenue and improved net income, but with a material one-time tariff refund component and ongoing FX/shipping headwinds.
What to watch
Gross margin benefited from the tariff refund but was offset by weaker USD versus Euro, higher shipping expense, and service revenue growth that carries lower gross margins than product sales.
Background
The company filed an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting second-quarter 2026 results and discussing growth drivers and the IEEPA tariff refund.
Ticker impact
Nephros reported Q2 ended June 30, 2026 net revenue of $6.0M (+36% YoY) and $1.2M net income, including a $0.6M tariff refund benefit.
Near-term bias to the upside on the reported growth and profitability, but traders may discount the tariff-refund component and watch for normalization.
This is a primary SEC 8-K earnings release with specific quarterly figures and an explicit one-time IEEPA tariff refund recorded as a reduction of cost of goods sold, plus a booked receivable since the cash refund is not yet received.
Market effects
Water technology and filtration providers may see read-across interest if tariff-related refunds and recurring programmatic revenue trends appear durable.
Limited, company-specific impact centered on a US-listed microcap.
Minimal, though the IEEPA tariff refund and FX-driven cost effects highlight cross-currency and trade-policy sensitivity.
Counterpoint
The headline profitability improvement is partly driven by a one-time tariff refund; underlying gross margin and service mix may be less favorable once the benefit normalizes.
Key entities
- public_companyNephros, Inc.
Nasdaq-listed water technology company reporting Q2 2026 financial results and discussing growth and tariff refund effects.
- regulatory_eventIEEPA tariff refund
Tariffs previously paid under the International Emergency Economic Powers Act were declared invalid; Nephros received approval for a refund and recorded a $0.6M benefit.
- regulatory_processCBP refund process
Customs and Border Protection refund process referenced as the mechanism after the Supreme Court decision.
